Aligos Therapeutics Inc (ALGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 12-2018 | |
| Operating Expenses | 21,557 | 21,271 | 20,721 | 0 | 0 |
| Operating Income | -21,557 | -21,271 | -20,721 | N/A | N/A |
| Other Income | -11,740 | 415 | 692 | 0 | 0 |
| Pre-tax Income | -33,297 | -20,856 | -20,029 | 0 | 0 |
| Income Tax | N/A | -59 | N/A | N/A | N/A |
| Net Income Continuous | -33,297 | -20,797 | -20,029 | N/A | N/A |
| Net Income | $-33,297 | $-20,797 | $-20,029 | $N/A | $N/A |
| EPS Basic Total Ops | -275.00 | -185.00 | -189.00 | N/A | N/A |
| EPS Basic Continuous Ops | -274.91 | -184.96 | -189.02 | N/A | N/A |
| EPS Diluted Total Ops | -275.00 | -185.00 | -189.00 | N/A | N/A |
| EPS Diluted Continuous Ops | -274.91 | -184.96 | -189.02 | N/A | N/A |
| EBITDA(a) | $-20,581 | $-20,089 | $-20,256 | $N/A | $N/A |